triamterene has been researched along with Liver Diseases in 7 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Comparing these data with results after oral application of TA the bioavailability of TA was 52% and the extent of absorption 83%." | 1.27 | [Pharmacokinetics of triamterene in healthy subjects and patients with liver and kidney function disorders]. ( Gilfrich, HJ; Knauf, H; Möhrke, W; Mutschler, E; Völger, KD, 1983) |
| " Comparing these data with results after oral application of TA the bioavailability of TA was 52% and the extent of absorption 83%." | 1.27 | Pharmacokinetics of triamterene. ( Gilfrich, HJ; Knauf, H; Möhrke, W; Mutschler, E; Völger, KD, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mills, WD | 1 |
| Greenhaw, RM | 1 |
| Wang, JMP | 1 |
| Mutschler, E | 2 |
| Gilfrich, HJ | 2 |
| Knauf, H | 2 |
| Möhrke, W | 2 |
| Völger, KD | 2 |
| Affrime, M | 1 |
| Reidenberg, MM | 1 |
| Weiss, M | 1 |
| Lant, A | 1 |
| Reubi, FC | 1 |
2 reviews available for triamterene and Liver Diseases
| Article | Year |
|---|---|
Diuretics. Clinical pharmacology and therapeutic use (Part II).
Topics: Amiloride; Canrenoic Acid; Diuretics; Diuretics, Osmotic; Drug Interactions; Hearing Disorders; Hear | 1985 |
Combination diuretic drug therapy.
Topics: Amiloride; Benzothiadiazines; Diet; Diuretics; Drug Therapy, Combination; Ethacrynic Acid; Furosemid | 1971 |
5 other studies available for triamterene and Liver Diseases
| Article | Year |
|---|---|
A Medical Review of Fatal High-G U.S. Aerobatic Accidents.
Topics: Accidents, Aviation; Aerospace Medicine; Alcoholism; Alprazolam; Case-Control Studies; Clonidine; Da | 2019 |
[Pharmacokinetics of triamterene in healthy subjects and patients with liver and kidney function disorders].
Topics: Adult; Age Factors; Aged; Biological Availability; Chemical Phenomena; Chemistry; Female; Half-Life; | 1983 |
Pharmacokinetics of triamterene.
Topics: Age Factors; Aged; Biological Availability; Female; Humans; In Vitro Techniques; Kidney Diseases; Ki | 1983 |
The protein binding of some drugs in plasma from patients with alcoholic liver disease.
Topics: Alcoholism; Blood Proteins; Chronic Disease; Dapsone; Fluoresceins; Humans; Liver Diseases; Pharmace | 1975 |
Use of metabolite AUC data in bioavailability studies to discriminate between absorption and first-pass extraction.
Topics: Absorption; Antipyrine; Biological Availability; Caffeine; Diphenhydramine; Dose-Response Relationsh | 1990 |